What Is The Current and Historic Market Size Analysis Of The Bioimpedance Analyzers Market?
The bioimpedance analyzers market has seen considerable growth due to a variety of factors.
• The bioimpedance analyzers market has experienced rapid growth in recent years. It will increase from $0.59 billion in 2024 to $0.67 billion in 2025, at a CAGR of 14.5%.
Factors behind this growth include the obesity epidemic, changing lifestyles, the rise in home deliveries, higher rates of blood disorders such as anemia and leukemia, the prevalence of chronic diseases, and the aging population.
What Is The Forecast For The Bioimpedance Analyzers Market Size?
The bioimpedance analyzers market is expected to maintain its strong growth trajectory in upcoming years.
• The bioimpedance analyzers market is projected to grow to $1.14 billion by 2029, with a CAGR of 14.1%.
Factors contributing to this growth include the expansion of healthcare infrastructure, increased funding, health awareness, higher healthcare spending, and rising junk food consumption. Major trends include technological advancements, personalized healthcare solutions, telehealth adoption, non-invasive technologies, and wearable technology integration.
What Are The Essential Drivers Behind The Growth Of The Bioimpedance Analyzers Market?
Growing concerns about obesity are likely to contribute to the expansion of the bioimpedance analyzers market. Obesity is a significant health issue, and the increasing availability of unhealthy foods and sedentary lifestyles are contributing to its rise. Bioimpedance analyzers provide valuable insights into body composition, helping manage obesity through personalized treatment plans. For example, obesity rates are expected to reach 2.7 billion by 2025, increasing the demand for bioimpedance analyzers.
How Is The Global Bioimpedance Analyzers Market Divided Into Key Segments?
The bioimpedance analyzers market covered in this report is segmented –
1) By Type: Multi Frequency, Single Frequency, Dual Frequency
2) By Modality: Wired Bioimpedance, Wireless Bioimpedance
3) By Application: Whole Body Measurement, Segmental Body Measurement
4) By End User: Hospitals, Fitness Clubs And Wellness Centers, Home Users, Other End-Users
Subsegments:
1) By Multi-Frequency: Bioimpedance Analyzers With Multiple Frequency Settings, Multi-Frequency Body Composition Analyzers
2) By Single-Frequency: Single-Frequency Bioimpedance Analyzers, Single-Frequency Body Composition Analyzers
3) By Dual-Frequency: Dual-Frequency Bioimpedance Analyzers, Dual-Frequency Body Composition Analyzers
Pre-Book The Bioimpedance Analyzers Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Bioimpedance Analyzers Market?
Companies in the bioimpedance analyzer market are focusing on developing body composition scales to offer more accurate and detailed health assessments. These scales use bioimpedance analysis (BIA) to measure body composition, providing insights into various health indices beyond just weight. For example, in September 2022, Xiaomi launched an eight-electrode body composition scale that uses dual-frequency bioimpedance technology to deliver precise measurements of body fat, water, muscle, and other body metrics, offering 35 types of body composition analysis reports.
Who Are the Key Players In The Bioimpedance Analyzers Market?
Major companies operating in the bioimpedance analyzers market are:
• Xiaomi Corporation
• Omron Corporation
• Beurer GmbH
• InBody Co Ltd.
• Seca GmbH & Co.
• Withings
• Lumsail Industrial Inc.
• Zurich Instruments Ltd.
• RJL Systems Inc.
• ImpediMed Limited
• Biodynamics Corporation
• Charder Electronic Co Ltd.
• Akern Srl
• Bioparhom
• BioTekna Limited
• Bodystat Ltd.
• EVOLT 360 Limited
• Maltron International Ltd.
• Tanita Corporation
• Tongfang Health Technology (Beijing) Co.Ltd
What Are The Regional Insights Into The Bioimpedance Analyzers Market?
North America was the largest region in the bioimpedance analyzer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioimpedance analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
